- Willkommen bei ZOLL LifeVest
- Clinical Trials Register
- Bestselling Series
- ESC Clinical Practice Guidelines
Willkommen bei ZOLL LifeVest
Cardiac catherization of the coronary arteries is always recommended when there is a sound assumption that the blood flow in the arteries is impaired and leads to a reduced blood supply of the heart muscle. For this purpose, I usually puncture the right or left radial artery [see below] and introduce a small canule with a diameter of around 2mm in the artery.
The vessels shown on cine-angiography are then assessed for further proceeding. Consequences after a diagnostic coronary angiography.
- A Mulher de Atenas e Outras Helenas (Portuguese Edition);
- Main Navigation.
- France - Amérique latine : Croisements de lettres et de voies (Espaces littéraires) (French Edition)!
The assessment of the coronary arteries always has three possible conseuqences:. Possible textbooks: Dr. About myself Cardiac catheterization.
Clinical Trials Register
Termine nach Vereinbarung. Select Rare Disease:. IMP with orphan designation in the indication. Orphan Designation Number:. Results Status: Trials with results Trials without results.
Clear advanced search filters. Date on which this record was first entered in the EudraCT database:. View results.
- The Discrepancy Between Social and Medical Rehabilitation of Patients with Coronary Heart Disease.
- G-Strophanthin - A 'New' Approach for Heart Disease | World Research Foundation.
- Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease.
- Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease;
Title of the trial for lay people, in easily understood, i. After myocardial infarction patients suffer from insufficient blood and oxygen supply. This often results in a reduced heart function attributed to irreversible loss of viable cardiomyocytes. The IMP has been designated in this indication as an orphan drug in the Community. Committee on Advanced therapies CAT has issued a classification for this product. Combination product that includes a device, but does not involve an Advanced Therapy.
Coronary artery disease after myocardial infarction with an indication for CABG surgery. Patients suffering from a heart attack with reduced heart function who are in need of a bypass surgey in order to enhance oxygen supply of their heart. To determine whether injection of autologously derived bone marrow stem cells yields a functional benefit in addition to the coronary artery bypass graft CABG operation as determined by left ventricular heart function LVEF-MRI. To determine the effects of an injection of autologously derived bone marrow stem cells on physical exercise capacity, cardiac function, safety and quality of life QoL.
Coronary artery disease after myocardial infarction with indication for CABG surgery 2. Informed consent of the patient 5.
ESC Clinical Practice Guidelines
Are not pregnant and do not plan to become pregnant during the study. Females with childbearing potential must provide a negative pregnancy test within days before OP and must be using oral or injectable contraception non childbearing potential is defined as post-menopausal for at least 1 year or surgical sterilization or hysterectomy at least 3 months before study start.
Einwilligung des Patienten 5. Patients will be entered into this study only if they meet none of the following criteria: 1. Emergency operation 2. Presence of any moderate-severe valvular heart disease requiring concomitant valve replacement or reconstruction 3. Acute myocardial infarction within last 2 weeks 5.
Impaired ability to comprehend the study information 7. Absence of written informed consent 8. Treatment with any investigational drug within the previous 30 days 9.